Literature DB >> 33637878

Size-based characterization of adalimumab and TNF-α interactions using flow induced dispersion analysis: assessment of avidity-stabilized multiple bound species.

Morten E Pedersen1,2, Ragna M S Haegebaert2, Jesper Østergaard2, Henrik Jensen3,4.   

Abstract

The understanding and characterization of protein interactions is crucial for elucidation of complicated biomolecular processes as well as for the development of new biopharmaceutical therapies. Often, protein interactions involve multiple binding, avidity, oligomerization, and are dependent on the local environment. Current analytical methodologies are unable to provide a detailed mechanistic characterization considering all these parameters, since they often rely on surface immobilization, cannot measure under biorelevant conditions, or do not feature a structurally-related readout for indicating formation of multiple bound species. In this work, we report the use of flow induced dispersion analysis (FIDA) for in-solution characterization of complex protein interactions under in vivo like conditions. FIDA is an immobilization-free ligand binding methodology employing Taylor dispersion analysis for measuring the hydrodynamic radius (size) of biomolecular complexes. Here, the FIDA technology is utilized for a size-based characterization of the interaction between TNF-α and adalimumab. We report concentration-dependent complex sizes, binding affinities (Kd), kinetics, and higher order stoichiometries, thus providing essential information on the TNF-α-adalimumab binding mechanism. Furthermore, it is shown that the avidity stabilized complexes involving formation of multiple non-covalent bonds are formed on a longer timescale than the primary complexes formed in a simple 1 to 1 binding event.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33637878      PMCID: PMC7910425          DOI: 10.1038/s41598-021-84113-z

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  27 in total

1.  Aggregation, immune complexes and immunogenicity.

Authors:  Roy Jefferis
Journal:  MAbs       Date:  2011-11-01       Impact factor: 5.857

2.  Quality control and analytical techniques for biopharmaceuticals.

Authors:  C Jane Robinson; Christopher Jones
Journal:  Bioanalysis       Date:  2011-01       Impact factor: 2.681

3.  Oligomeric tumour necrosis factor alpha slowly converts into inactive forms at bioactive levels.

Authors:  A Corti; G Fassina; F Marcucci; E Barbanti; G Cassani
Journal:  Biochem J       Date:  1992-06-15       Impact factor: 3.857

Review 4.  Target deconvolution strategies in drug discovery.

Authors:  Georg C Terstappen; Christina Schlüpen; Roberto Raggiaschi; Giovanni Gaviraghi
Journal:  Nat Rev Drug Discov       Date:  2007-11       Impact factor: 84.694

5.  Points to consider in the manufacture and testing of monoclonal antibody products for human use (1997). U.S. Food and Drug Administration Center for Biologics Evaluation and Research.

Authors: 
Journal:  J Immunother       Date:  1997-05       Impact factor: 4.456

6.  Protein Characterization in 3D: Size, Folding, and Functional Assessment in a Unified Approach.

Authors:  Morten E Pedersen; Sarah I Gad; Jesper Østergaard; Henrik Jensen
Journal:  Anal Chem       Date:  2019-04-05       Impact factor: 6.986

7.  Taylor dispersion analysis compared to dynamic light scattering for the size analysis of therapeutic peptides and proteins and their aggregates.

Authors:  Andrea Hawe; Wendy L Hulse; Wim Jiskoot; Robert T Forbes
Journal:  Pharm Res       Date:  2011-05-11       Impact factor: 4.200

8.  Higher order structures of Adalimumab, Infliximab and their complexes with TNFα revealed by electron microscopy.

Authors:  Bich Ngoc Tran; Siew Leong Chan; Chloe Ng; Jian Shi; Ivan Correia; Czeslaw Radziejewski; Paul Matsudaira
Journal:  Protein Sci       Date:  2017-11-14       Impact factor: 6.725

9.  Binding characteristics of tumor necrosis factor receptor-Fc fusion proteins vs anti-tumor necrosis factor mAbs.

Authors:  Tadahiko Kohno; Lei-Ting T Tam; Seth R Stevens; James S Louie
Journal:  J Investig Dermatol Symp Proc       Date:  2007-05

10.  In-Solution IgG Titer Determination in Fermentation Broth Using Affibodies and Flow-Induced Dispersion Analysis.

Authors:  Morten E Pedersen; Jesper Østergaard; Henrik Jensen
Journal:  ACS Omega       Date:  2020-04-28
View more
  4 in total

1.  Immobilization-Free Binding and Affinity Characterization of Higher Order Bispecific Antibody Complexes Using Size-Based Microfluidics.

Authors:  Andreas V Madsen; Oscar Mejias-Gomez; Lasse E Pedersen; Kerstin Skovgaard; Peter Kristensen; Steffen Goletz
Journal:  Anal Chem       Date:  2022-09-27       Impact factor: 8.008

2.  Quantification of Structural Integrity and Stability Using Nanograms of Protein by Flow-Induced Dispersion Analysis.

Authors:  Morten E Pedersen; Jesper Østergaard; Henrik Jensen
Journal:  Molecules       Date:  2022-04-13       Impact factor: 4.927

3.  Assessment of immunogenicity and drug activity in patient sera by flow-induced dispersion analysis.

Authors:  Morten E Pedersen; Jesper Østergaard; Bente Glintborg; Merete L Hetland; Henrik Jensen
Journal:  Sci Rep       Date:  2022-03-18       Impact factor: 4.379

4.  HLAII peptide presentation of infliximab increases when complexed with TNF.

Authors:  Andrea Casasola-LaMacchia; Robert Joseph Seward; Sophie Tourdot; Matthew Willetts; Gary Kruppa; Michael J Agostino; Gabrielle Bergeron; Nathalie Ahyi-Amendah; Andrew Ciarla; Zhaojiang Lu; Hai-Young Kim; Timothy P Hickling; Hendrik Neubert
Journal:  Front Immunol       Date:  2022-09-13       Impact factor: 8.786

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.